TuBerculosis Vaccine Initiative (TBVI)
TBVI is an independent non-profit foundation that facilitates the development of new vaccines to protect future generations against tuberculosis.
We financially support and bring expertise to an integrated network of over 40 universities, institutes and industries to develop more effective, safe vaccines that will be globally accessible and affordable. Research conducted by our mostly European based network has already resulted in promising vaccine discoveries.
New vaccines are urgently needed to stop tuberculosis. Every year around 9 million new cases of this infectious disease are recorded. Every year almost 2 million people die of TB, equaling one death every 18 seconds.
Why invest in TB?
Investing in TB vaccines has potentially huge returns on investment. Both in lives saved and in euros.
Read more ยป
Second global forum on TB vaccines
This Forum (Tallinn, Estonia Sep 21-24, 2010) will review progress made in TB vaccine field over last decade.
Read more>>
TBVI News

- 26.Aug.10 | Prof. Dr. Stefan Kaufmann new...
- 22.Jul.10 | Position available: Advocacy...
- 08.Jul.10 | TBVI receives grant Calouste...
- 06.Jul.10 | TBVI and GlaxoSmithKline...
Other TB News
- 02.Sep.10 | Feasibility, reliability and...
- 01.Sep.10 | Rapid Molecular Detection of...
- 01.Sep.10 | New TB Diagnostic Proves...
- 01.Sep.10 | Effectiveness of BCG...

